Cymbalta gets Mixed Reception

Eli Lilly's new antidepressant Cymbalta should be hitting the streets in the U.S. any day now. The company hopes that it has found a money-maker, since It's flagship antidepressant Prozac is now available in a cheaper generic version.

Cymbalta (duloxetine) is one of a new class of antidepressants that targets both serotonin and norepinephrine. It's also the drug that a college student was taking when she hanged herself in a Lilly research facility.

Read more about Cymbalta